Prevalence and role of methylenetetrahydrofolate reductase 677 C→T and 1298 A→C polymorphisms in coronary artery disease in Arabs

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 10, 2003, Pages 1349-1352

  Abu Amero, Khaled K ^a   Wyngaard, Carol A ^b   Dzimiri, Nduna ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ANGIOGRAPHY; ARAB; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; RESTRICTION MAPPING; RISK FACTOR;

ADULT; ARABS; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0141891858     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kluijtmans LA, Kastelein JJ, Lindemans J, et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1997:96:2573-2577.
2. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001:47:661-666.
3. Frost P, Bolm MJ, Lios R. A candidate genetic risk factor vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
4. Weisberg I, Tan P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decrease enzyme activity. Mol Genet Metab. 1998;64:169-172.
5. Payne DA, Chamoun AJ, Seifert SI, Stouffer GA. MTHFR 677 C→T mutation: a predictor of early-onset, coronary artery disease. Thromb Res. 2001;103:275-279.
6. Szczeklik A, Sanak M, Jankowski M, et al. Mutation A1298C of methyleneletrahydrofolate reduclase: risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet. 2001;101:36-39.
7. Mager A, Lalezari S, Shohat T, et al. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation. 1999;100:2406-2410.
8. Kawashiri M, Kajinami K, Nohara A, et. al. Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia. Am J Cardiol. 2000;86:840-845.
9. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol. 2001;87:1361-1366.
10. Szczeklik A, Sanak M, Jankowski M, et al. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocycteinemia. Am J Med Genet. 2001;101:36-39.
11. Jee SH, Beaty TH, Suh I, Yoon Y, Appel LJ. The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations. Atherosclerosis. 2000;153:161-168.
12. Morita H, Taguchi J, Kurihara, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032-2036.
13. Rothenbacher D, Fischer HG, Hoffmeister A, et al. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory hemostatic and lipid parameters. Atherosclerosis. 2002;162:193-200.
14. Mukherjee M, Joshi S, Bagadi S, Dalvi M, Rao A, Shetty KR. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet. 2002;61:155-159.
15. Zhang G, Dai C. Gene polymorphism of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res. 2001;104:187-195.
16. Hong SH, Song J, Kim JQ. Genetic variation of methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and new polymorphism in intron 7. Mol Cell Probe. 2001;15:119-123.
17. Kim CH, Hwang KY, Choi TM, Shin WY, Hong SY. The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease. Int. J. Cardiol. 2001;78:13-17.
18. Meisel C, Cascorbi I, Gerloff T, et al. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Atheroscleosis. 2001;154:651-658.
19. Hsu LA, Ko YL, Wang SM, et al. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001;51:41-45.
20. Loktonov A, Vorster H, O'Neill IK, et al. Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans. Atherosclerosis. 1999;145:125-135.
21. Schwahn B, Rozen R. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacol Genomics 2001;1:189-201.
22. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset S. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmcol Sci. 2001;22:195-201.
23. Botto L, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862-877.
24. Ruiz-Arguelles GJ, Graces-Eisele J, Reyes-Nunez V, Ramirez-Cisneros FJ. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos. Am J Hematol. 2001;66:28-31.
25. Czeizel E, Timar L, Botto L. Prevalence of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism (C677T) in the Hungarian population. Orvosi Hetilap. 2001;142:1227-1229.
26. Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Prevalence of the C677T methylenetetrahydrofolate reductase mutation in Thai patients with deep vein thrombosis. Acta Haematol. 2000;103:191-196.
27. Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb/Hemost. 2000;6:104-107.
28. van der Put NM, Gabreels F, Stevens EM. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects. Am J Hum Gene. 1998;62:1044-1051.
29. Song C, Xing D, Tan W, Wei Q, Lin D. Methylenetetrahydrofolate reductase polymorphisms increases risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 2001;61:3272-3275.
30. Franco RF, Morelli V, Lourenco D, et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol. 1999;105:556-559.
31. Trembath D, Sherbondy AL, Vandyke DC. Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology. 1999;59:331-341.
32. Skibola CF, Smith M, Kane E, et. al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. PNAS. 1999;96:12 810-12 815.
33. Raslova K, Bederova A, Gasparovic J, Blazicek P, Smolkova B. Effect of diet and 677 C→T 5,10-methylenetetrahydrofolate reductase genotypes on plasma homocysteine concentrations in Slovak adolescent population. Physiol Res. 2000;49:651-658.
34. Hanson N, Aras O, Yang F, Tsai M. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post- methionine load homocysteine in vascular disease. Clin Chem. 2001;47:661-666.
35. Chambers JC, Ireland H, Thompson E, et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians. Arterioscl Thromb Vasc Biol. 2000;20:2448-2452.
36. Joubran R, Asmi M, Busjahn A, Vergopoulos A, Luft F, Jouma M. Homocysteine levels and coronary artery disease in Syria. J Cardiovasc Risk. 1998;5:257-261.
37. Al-Humaidi MA. Probability of coronary artery disease among patients attending primary health care centers in southwest Saudi Arabia. Ethn Dis. 2000;10:350-356.
38. Osman AK, Al-Nozha MM. Risk factors of coronary artery disease in different regions of Saudi Arabia. Eastem Mediterranean Health J. 2000;6:465-474.
39. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol. 2001;87:1361-1366.